Angiotech Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Angiotech Pharmaceuticals, Inc. holds 86 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 53 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 9 Nice Classification classes. The owner is based in Vancouver.
1618 Station Street
Vancouver V6A1B6 , CA
Showing of trademarks Trademarks
Trademark Classifications
Angiotech Pharmaceuticals, Inc.'s trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Angiotech Pharmaceuticals, Inc. have?
Angiotech Pharmaceuticals, Inc. has 86 U.S. trademarks filed with the USPTO.
What trademark classes does Angiotech Pharmaceuticals, Inc. file in?
Angiotech Pharmaceuticals, Inc. files trademarks across 9 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What is Angiotech Pharmaceuticals, Inc.'s trademark registration success rate?
Angiotech Pharmaceuticals, Inc. has a 0% trademark registration rate, with 0 out of 86 resolved applications resulting in successful registration. Currently, 0 applications are pending review.